secwatch / observer
8-K filed February 8, 2024, 6:59 PM ET ticker AGL CIK 0001831097
leadership confidence high sentiment neutral materiality 0.60

agilon health names Karthik Rao interim CMO effective March 1; Benjamin Kornitzer to serve as special advisor

agilon health, inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Karthik Rao

Interim Chief Medical Officer
AGL · agilon health, inc.
Effective
2024-03-01
Filed
February 8, 2024, 6:59 PM ET
Until a successor is named, Dr. Karthik Rao, senior medical director and vice president, network performance, will serve as interim CMO.
Role change

Benjamin Kornitzer, M.D.

Chief Medical Officer
AGL · agilon health, inc.
Effective
2024-03-01
Filed
February 8, 2024, 6:59 PM ET
Effective March 1, 2024, Benjamin Kornitzer, M.D., will assume a strategic role as special advisor to agilon health and will transition from his role as chief medical officer (CMO).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Karthik Rao was appointed as Interim Chief Medical Officer at agilon health, inc..

Action
appointed
Role
Interim Chief Medical Officer
Exact text from the filing
Until a successor is named, Dr. Karthik Rao, senior medical director and vice president, network performance, will serve as interim CMO.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Benjamin Kornitzer, M.D. changed role as Chief Medical Officer at agilon health, inc..

Action
transitioned
Role
Chief Medical Officer
Exact text from the filing
Effective March 1, 2024, Benjamin Kornitzer, M.D., will assume a strategic role as special advisor to agilon health and will transition from his role as chief medical officer (CMO).
View on SEC.gov

agilon health, inc. filing history →

Source: SEC EDGAR
accession 0001628280-24-003867
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.